Cargando…

Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever

OBJECTIVE: Familial Mediterranean fever (FMF) is an autosomal recessive disease due to a MEFV gene mutation. Since Helicobacter pylori infection has been described to increase the severity and frequency of FMF attacks, we evaluate if overgrowth of small intestinal bacterial (SIBO), associated with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verrecchia, E., Sicignano, L. L., La Regina, M., Nucera, G., Patisso, I., Cerrito, L., Montalto, M., Gasbarrini, A., Manna, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742903/ https://www.ncbi.nlm.nih.gov/pubmed/29379228 http://dx.doi.org/10.1155/2017/7461426

Ejemplares similares

Colchicine trial in PFAPA Syndrome and MEFV-negative patients
por: Kadhim, C, et al.
Publicado: (2015)

Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review
por: Talerico, Rosa, et al.
Publicado: (2020)

Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome
por: Cantarini, Luca, et al.
Publicado: (2017)

Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report
por: Massaro, Maria Grazia, et al.
Publicado: (2020)

Intestinal malrotation as a misdiagnosis of pediatric colchicine resistant familial Mediterranean fever
por: Heshin-Bekenstein, Merav, et al.
Publicado: (2015)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
por: Gatta, L., et al.
Publicado: (2017)

Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma
por: Langenberg-Ververgaert, Karin P.S., et al.
Publicado: (2018)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
por: El Hasbani, Georges, et al.
Publicado: (2019)

Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
por: Sener, Seher, et al.
Publicado: (2023)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever
por: Köhler, Birgit Maria, et al.
Publicado: (2018)

Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine
por: Berdeli, Afig, et al.
Publicado: (2019)

Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
por: Yücel, Burcu Bozkaya, et al.
Publicado: (2021)

Comparison of Different Pharmaceutical Preparations of Colchicine in Children with Familial Mediterranean Fever: Is Colchicine Opocalcium a Good Alternative?
por: Türkuçar, Serkan, et al.
Publicado: (2021)

Does switching from coated colchicine to compressed colchicine improves treatment response in patients with familial Mediterranean fever?
por: Öner, Nimet, et al.
Publicado: (2023)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth syndrome in children
por: Siniewicz-Luzeńczyk, Katarzyna, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth in Alzheimer’s disease
por: Kowalski, Karol, et al.
Publicado: (2021)

The duodenal microbiome is altered in small intestinal bacterial overgrowth
por: Leite, Gabriela, et al.
Publicado: (2020)

Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort
por: Plauzolles, Anne, et al.
Publicado: (2022)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment
por: Odabas, Hatice
Publicado: (2006)

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever
por: Corsia, Alice, et al.
Publicado: (2017)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?
por: Omma, Ahmet, et al.
Publicado: (2021)

Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine
por: Talaat, Hala S., et al.
Publicado: (2020)

Link between hypothyroidism and small intestinal bacterial overgrowth
por: Patil, Anant D.
Publicado: (2014)

How to Recognize and Treat Small Intestinal Bacterial Overgrowth?
por: Skrzydło-Radomańska, Barbara, et al.
Publicado: (2022)

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine
por: Bahceci, Semiha Erdem, et al.
Publicado: (2015)

Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
por: Omma, Ahmet, et al.
Publicado: (2017)

COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review
por: Nas, Kemal, et al.
Publicado: (2021)

PFAPA syndrome as an hereditary autoinflamatory disorder
por: Kadhim, C, et al.
Publicado: (2015)

Intestinal Microbiome, Small Intestinal Bacterial Overgrowth and Inflammatory Bowel Diseases - What are the Connections?
por: ANDREI, M., et al.
Publicado: (2015)

Gastrointestinal complaints in runners are not due to small intestinal bacterial overgrowth
por: Schommer, Kai, et al.
Publicado: (2011)

Small Intestine Bacterial Overgrowth and Environmental Enteropathy in Bangladeshi Children
por: Donowitz, Jeffrey R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nr2uipc4tekbbu1a2mf022snbi